April 4, 2024 April 4, 2024Categories Announcements News StoriesThe Spring 2024 advocacy blog Considering Clinical Trials is now available
March 4, 2024 March 4, 2024Categories Press ReleasesPress Release: NCI-MATCH cancer trial discovers a potentially broader role for an established dual HER2-blocking treatment
January 17, 2024 January 17, 2024Categories Press ReleasesPress Release: ECOG-ACRIN research team led by Michael Atkins, MD receives Journal of Clinical Oncology 2023 Paper of the Year
December 11, 2023 December 11, 2023Categories Press ReleasesPress Release: Encouraging results in mantle cell lymphoma from PrECOG
October 10, 2023 October 10, 2023Categories Announcements News StoriesThe Fall 2023 advocacy blog Considering Clinical Trials is now available
July 20, 2023 July 20, 2023Categories Press ReleasesPress Release: ECOG-ACRIN adds a new treatment trial to the ComboMATCH precision medicine initiative
June 30, 2023 June 30, 2023Categories Announcements News StoriesThe May/June 2023 News from ECOG-ACRIN blog is now available
